Literature DB >> 33485118

5-Fluorouracil (5-FU) resistance and the new strategy to enhance the sensitivity against cancer: Implication of DNA repair inhibition.

Chinmayee Sethy1, Chanakya Nath Kundu2.   

Abstract

5-Fluorouracil (5-FU) has been an important anti-cancer drug to date. With an increase in the knowledge of its mechanism of action, various treatment modalities have been developed over the past few decades to increase its anti-cancer activity. But drug resistance has greatly affected the clinical use of 5-FU. Overcoming this chemoresistance is a challenge due to the presence of cancer stem cells like cells, cancer recurrence, metastasis, and angiogenesis. In this review, we have systematically discussed the mechanism of 5-FU resistance and advent strategies to increase the sensitivity of 5-FU therapy including resistance reversal. Special emphasis has been given to the cancer stem cells (CSCs) mediated 5-FU chemoresistance and its reversal process by different approaches including the DNA repair inhibition process.
Copyright © 2021. Published by Elsevier Masson SAS.

Entities:  

Keywords:  5-FU resistance; Angiogenesis; Cancer stemness; Combination therapy; DNA repair; MDR modulators

Mesh:

Substances:

Year:  2021        PMID: 33485118     DOI: 10.1016/j.biopha.2021.111285

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  25 in total

1.  Examination of Combined Treatment of Ginsenoside Rg3 and 5-Fluorouracil in Lung Adenocarcinoma Cells.

Authors:  Kuizhong Shan; Yujiang Deng; Zhiquan Du; Peiyu Yue; Sufang Yang
Journal:  Comput Math Methods Med       Date:  2022-06-28       Impact factor: 2.809

2.  UMAOH Calcium Phosphate Coatings Designed for Drug Delivery: Vancomycin, 5-Fluorouracil, Interferon α-2b Case.

Authors:  Konstantin A Prosolov; Ekaterina G Komarova; Ekaterina A Kazantseva; Aleksandr S Lozhkomoev; Sergei O Kazantsev; Olga V Bakina; Marina V Mishina; Anastasia P Zima; Sergei V Krivoshchekov; Igor A Khlusov; Yurii P Sharkeev
Journal:  Materials (Basel)       Date:  2022-07-01       Impact factor: 3.748

3.  Thymidylate Synthase Overexpression Drives the Invasive Phenotype in Colon Cancer Cells.

Authors:  Wojciech M Ciszewski; Małgorzata Chmielewska-Kassassir; Lucyna A Wozniak; Katarzyna Sobierajska
Journal:  Biomedicines       Date:  2022-05-29

4.  Identification of crucial genes of pyrimidine metabolism as biomarkers for gastric cancer prognosis.

Authors:  Zhengxin Wu; Jinshui Tan; Yifan Zhuang; Mengya Zhong; Yubo Xiong; Jingsong Ma; Yan Yang; Zhi Gao; Jiabao Zhao; Zhijian Ye; Huiwen Zhou; Yuekun Zhu; Haijie Lu; Xuehui Hong
Journal:  Cancer Cell Int       Date:  2021-12-14       Impact factor: 5.722

Review 5.  Curcumin as an Enhancer of Therapeutic Efficiency of Chemotherapy Drugs in Breast Cancer.

Authors:  Reyhaneh Farghadani; Rakesh Naidu
Journal:  Int J Mol Sci       Date:  2022-02-15       Impact factor: 5.923

Review 6.  Overcoming Radiation Resistance in Gliomas by Targeting Metabolism and DNA Repair Pathways.

Authors:  Wei Meng; Joshua D Palmer; Michael Siedow; Saikh Jaharul Haque; Arnab Chakravarti
Journal:  Int J Mol Sci       Date:  2022-02-17       Impact factor: 5.923

7.  Integrated Chromatin Accessibility and Transcriptome Landscapes of 5-Fluorouracil-Resistant Colon Cancer Cells.

Authors:  Bishu Zhang; Jiewei Lin; Jiaqiang Zhang; Xuelong Wang; Xiaxing Deng
Journal:  Front Cell Dev Biol       Date:  2022-02-17

Review 8.  Long Non-Coding RNA in Gastric Cancer: Mechanisms and Clinical Implications for Drug Resistance.

Authors:  Ying Liu; Xiang Ao; Yu Wang; Xiaoge Li; Jianxun Wang
Journal:  Front Oncol       Date:  2022-01-28       Impact factor: 6.244

Review 9.  Epigenetic Approaches to Overcome Fluoropyrimidines Resistance in Solid Tumors.

Authors:  Laura Grumetti; Rita Lombardi; Federica Iannelli; Biagio Pucci; Antonio Avallone; Elena Di Gennaro; Alfredo Budillon
Journal:  Cancers (Basel)       Date:  2022-01-29       Impact factor: 6.639

Review 10.  Serine hydroxymethyltransferase 2: a novel target for human cancer therapy.

Authors:  Min Xie; Dong-Sheng Pei
Journal:  Invest New Drugs       Date:  2021-07-03       Impact factor: 3.850

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.